Topic

Articles

Developing new pathways to overcome study-related challenges is key to realizing the promise of the latest gene therapies.

The Rise of Gene Therapy: Advanced Regulatory, Site, and Enrollment Considerations

How partnering with a CRO that has experience in both dermatology and innovative trial approaches can help sponsors differentiate their studies and facilitate recruitment. 

Navigating the New World of Dermatology Trials

Thousands of trials have been halted as a consequence of the coronavirus pandemic, slowing the pace of scientific progress dramatically.

Cancer Won’t Wait for COVID to End: Conducting Trials Amid the Coronavirus Pandemic

Today's reality and the hopes of tomorrow of the COVID-19 pandemic—an updated mapping of vaccines authorized by regulatory bodies and those close to it.

Vaccines Approved and Under Development Against COVID-19

Though the fields of immunotherapy and cell and gene therapies have seen significant growth since April 2012, CGT clinical research remains a challenge.

Best Practices in Managing CGT From Protocol Design to Data Management

Successful collaborations between Pharma/Biotech/Device industries and CROs will play a key role in an effective fight against the global COVID-19 pandemic.

The Current Status of European Research Related to COVID-19: The EUCROF Perspective

Evolving technologies include modification of receptors on T cells to better target tumor microenvironments and minimize off-tumor cross-reactivity. 

Facilitating Adoptive Cell Therapy Clinical Trials

87% of people surveyed said they had no concerns about a decentralized approach to clinical trials. 

Recent Data Shows Positive Attitudes for Decentralized Trials in Rare Disease Patients

Sangamo executives, Melita Sun Jung and Amy Pooler, discuss the future of genomic medicines for autism spectrum disorder.

A New Interest in Autism Genomic Therapy Development 

Moe Alsumidaie sits down with Ping Yeh, CEO and co-founder of StemoniX, to discuss how MicroOrgans will transform preclinical and clinical development in challenging areas like Alzheimer’s.

Therapeutic Areas